UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma Patients

NCT00113919 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
14
Enrollment
OTHER
Sponsor class

Stopped Due to poor accrual

Conditions

Interventions

Sponsor

University of Arkansas